Is increased chronological age a contraindication to debulking surgery for elderly patients with advanced ovarian cancer?

References

• Aletti GD, Eisenhauer EL, Santillan A, Axtell A, Aletti G, Holschneider C, et al. 2011. Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment. Gynecologic Oncology 120:23–28.
   PubMed Web of Science ®Google Scholar
• Bun S, Yunokawa M, Ebata T, Kobayashi Kato M, Shimoi T, Kato T, Tamura K. 2019. Feasibility of initial treatment in elderly patients with ovarian cancer in Japan: a retrospective study. International Journal of Clinical Oncology 24:1111–1118.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 40:373–383.
   PubMedGoogle Scholar
• Chéreau E, Ballester M, Selle F, Rouzier R, Daraï E. 2011. Ovarian cancer in the elderly: impact of surgery on morbidity and survival. European Journal of Surgical Oncology 37:537–542.
   PubMed Web of Science ®Google Scholar
• Fanfani F, Fagotti A, Salerno MG, Margariti PA, Gagliardi ML, Gallotta V, et al. 2012. Elderly and very elderly advanced ovarian cancer patients: does the age influence the surgical management? European Journal of Surgical Oncology 38:1204–1210.
   PubMed Web of Science ®Google Scholar
• Freyer G, Tew WP, Moore KN. 2013. Treatment and trials: ovarian cancer in older women. American Society of Clinical Oncology Educational Book 227–235.
   Google Scholar
• Glasheen WP, Cordier T, Gumpina R, Haugh G, Davis J, Renda A. 2019. Charlson Comorbidity Index: ICD-9 update and ICD-10 translation. American Health & Drug Benefits 12:188–197.
   PubMed Web of Science ®Google Scholar
• Hilpert F, du Bois A, Greimel ER, Hedderich J, Krause G, Venhoff L, et al. 2007. Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged > or = 70 years with advanced ovarian cancer – a study by the AGO OVAR Germany. Annals of Oncology 18:282–287.
   PubMed Web of Science ®Google Scholar
• Hurria A, Togawa K, Mohile SG, Owusu C, Klepin HD, Gross CP, et al. 2011. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. Journal of Clinical Oncology 29:3457–3465.
   PubMed Web of Science ®Google Scholar
• Jørgensen TL, Teiblum S, Paludan M, Poulsen LØ, Jørgensen AY, Bruun KH, et al. 2012. Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients. Gynecologic Oncology 127:367–374.
   PubMed Web of Science ®Google Scholar
• Joseph N, Clark RM, Dizon DS, Lee MS, Goodman A, Boruta D, Jr., et al. 2015. Delay in chemotherapy administration impacts survival in elderly patients with epithelial ovarian cancer. Gynecologic Oncology 137:401–405.
   PubMed Web of Science ®Google Scholar
• Kumar A, Janco JM, Mariani A, Bakkum-Gamez JN, Langstraat CL, Weaver AL, et al. 2016. Risk-prediction model of severe postoperative complications after primary debulking surgery for advanced ovarian cancer. Gynecologic Oncology 140:15–21.
   PubMed Web of Science ®Google Scholar
• Lin HS, Watts JN, Peel NM, Hubbard RE. 2016. Frailty and post-operative outcomes in older surgical patients: a systematic review. BMC Geriatrics 16:157.
   PubMed Web of Science ®Google Scholar
• Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. 2017. What is polypharmacy? A systematic review of definitions. BMC Geriatrics 17:230.
   PubMed Web of Science ®Google Scholar
• Mayhew D, Mendonca V, Murthy B. 2019. A review of ASA physical status – historical perspectives and modern developments. Anaesthesia 74:373–379.
   PubMed Web of Science ®Google Scholar
• McLean KA, Shah CA, Thompson SA, Gray HJ, Swensen RE, Goff BA. 2010. Ovarian cancer in the elderly: outcomes with neoadjuvant chemotherapy or primary cytoreduction. Gynecologic Oncology 118:43–46.
   PubMed Web of Science ®Google Scholar
• Monson K, Litvak DA, Bold RJ. 2003. Surgery in the aged population: surgical oncology. Archives of Surgery 138:1061–1067.
   PubMedGoogle Scholar
• Park SJ, Kim J, Kim SN, Lee EJ, Oh S, Seol A, et al. 2019. Practice patterns of surgery for advanced ovarian cancer: analysis from international surveys. Japanese Journal of Clinical Oncology 49:137–145.
   PubMed Web of Science ®Google Scholar
• Revenig LM, Canter DJ, Kim S, Liu Y, Sweeney JF, Sarmiento JM, et al. 2015. Report of a simplified frailty score predictive of short-term postoperative morbidity and mortality. Journal of the American College of Surgeons 220:904–911.e1.
   PubMed Web of Science ®Google Scholar
• Schuurman MS, Kruitwagen R, Portielje J, Roes EM, Lemmens V, van der Aa MA. 2018. Treatment and outcome of elderly patients with advanced stage ovarian cancer: a nationwide analysis. Gynecologic Oncology 149:270–274.
   PubMed Web of Science ®Google Scholar
• Strong VE, Selby LV, Sovel M, Disa JJ, Hoskins W, Dematteo R, et al. 2015. Development and assessment of Memorial Sloan Kettering Cancer Center's Surgical Secondary Events Grading System. Annals of Surgical Oncology 22:1061–1067.
   PubMed Web of Science ®Google Scholar
• Tew WP, Fleming GF. 2015. Treatment of ovarian cancer in the older woman. Gynecologic Oncology 136:136–142.
   PubMed Web of Science ®Google Scholar
• Thrall MM, Goff BA, Symons RG, Flum DR, Gray HJ. 2011. Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly. Obstetrics & Gynecology 118:537–547.
   PubMed Web of Science ®Google Scholar
• Tortorella L, Vizzielli G, Fusco D, Cho WC, Bernabei R, Scambia G, Colloca G. 2017. Ovarian cancer management in the oldest old: improving outcomes and tailoring treatments. Aging and Disease 8:677–684.
   PubMed Web of Science ®Google Scholar
• World Health Organization Regional Office for the Western Pacific. 2000. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia.
   Google Scholar
• Wright JD, Lewin SN, Deutsch I, Burke WM, Sun X, Neugut AI, et al. 2011. Defining the limits of radical cytoreductive surgery for ovarian cancer. Gynecologic Oncology 123:467–473.
   PubMed Web of Science ®Google Scholar